David Gancberg

Chromogenic in Situ Hybridization

Minna Tanner, David Gancberg, Angelo Di Leo et al. · American Journal Of Pathology · 2000 · 378 citations · Full text

Medicine, Cancer Biology, Oncology +15

Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

David Gancberg, Angelo Di Leo, Fátima Cardoso et al. · Annals of Oncology · 2002 · 309 citations · Full text

Medicine, Oncology, Pathology +15

HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil.

Angelo Di Leo, David Gancberg, Denis Larsimont et al. · PubMed · 2002 · 267 citations

Medicine, Cancer Biology, Oncology +15

Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome

Laurence Lespagnard, David Gancberg, G. Rouas et al. · International Journal of Cancer · 1999 · 107 citations

Life Sciences, Immunology, Oncology +17

HER-2 and topo-isomerase IIα as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide

Angelo Di Leo, Denis Larsimont, David Gancberg et al. · Annals of Oncology · 2001 · 107 citations

Medicine, Oncology, Pharmacology +17